The pathophysiological function of the forkhead transcription factor FOXN3 remains to be explored. Here we report that FOXN3 is a transcriptional repressor that is physically associated with the SIN3A repressor complex in estrogen receptor–positive (ER+) cells. RNA immunoprecipitation–coupled high-throughput sequencing identified that NEAT1, an estrogen-inducible long noncoding RNA, is required for FOXN3 interactions with the SIN3A complex. ChIP-Seq and deep sequencing of RNA genomic targets revealed that the FOXN3-NEAT1-SIN3A complex represses genes including GATA3 that are critically involved in epithelial-to-mesenchymal transition (EMT). We demonstrated that the FOXN3-NEAT1-SIN3A complex promotes EMT and invasion of breast cancer cells in vitro as well as dissemination and metastasis of breast cancer in vivo. Interestingly, the FOXN3-NEAT1-SIN3A complex transrepresses ER itself, forming a negative-feedback loop in transcription regulation. Elevation of both FOXN3 and NEAT1 expression during breast cancer progression corresponded to diminished GATA3 expression, and high levels of FOXN3 and NEAT1 strongly correlated with higher histological grades and poor prognosis. Our experiments uncovered that NEAT1 is a facultative component of the SIN3A complex, shedding light on the mechanistic actions of NEAT1 and the SIN3A complex. Further, our study identified the ERα-NEAT1-FOXN3/NEAT1/SIN3A-GATA3 axis that is implicated in breast cancer metastasis, providing a mechanistic insight into the pathophysiological function of FOXN3.
Wanjin Li, Zihan Zhang, Xinhua Liu, Xiao Cheng, Yi Zhang, Xiao Han, Yu Zhang, Shumeng Liu, Jianguo Yang, Bosen Xu, Lin He, Luyang Sun, Jing Liang, Yongfeng Shang
Title and authors | Publication | Year |
---|---|---|
MEX3B inhibits collagen production in eosinophilic nasal polyps by downregulating epithelial cell TGFBR3 mRNA stability
Liu Jin-Xin, Bo Liao, Yu Qihong, Chen Ao-Nan, Shi Ke-Tai, Liu Yi-Bo, Guo Cui-Lian, Zhe-Zheng Wang, Yin Yao, Li Pan, Xiang Lu, Kai Xu, Heng Wang, Ming Zeng, Chaohong Liu, Robert P. Schleimer, Wu Ning, Zheng Liu |
JCI Insight | 2023 |
Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling
Jinhui Lü, Qian Zhao, Yuefan Guo, Danni Li, Heying Xie, Cuicui Liu, Xin Hu, Suling Liu, Zhaoyuan Hou, Xunbin wei, Deyou Zheng, Richard Pestell, Zuoren Yu |
Journal of experimental & clinical cancer research : CR | 2023 |
Lncrna NEAT1 Regulates Th1/Th2 in Pediatric Asthma by Targeting MicroRNA-217/GATA3
Yan X, Liu H, Li T |
Iranian journal of public health | 2023 |
An autoimmune pleiotropic SNP modulates IRF5 alternative promoter usage through ZBTB3-mediated chromatin looping
Wang Z, Liang Q, Qian X, Hu B, Zheng Z, Wang J, Hu Y, Bao Z, Zhao K, Zhou Y, Feng X, Yi X, Li J, Shi J, Liu Z, Hao J, Chen K, Yu Y, Sham PC, Lu W, Wang X, Song W, Li MJ |
Nature Communications | 2023 |
A genome–wide CRISPR activation screen identifies SCREEM a novel SNAI1 super-enhancer demarcated by eRNAs
Uthaya Kumar DB, Yurieva M, Grassmann J, Kozhaya L, McBride CD, Unutmaz D, Williams A |
Frontiers in Molecular Biosciences | 2023 |
p38-mediated FOXN3 phosphorylation modulates lung inflammation and injury through the NF-κB signaling pathway.
Zhu X, Huang B, Zhao F, Lian J, He L, Zhang Y, Ji L, Zhang J, Yan X, Zeng T, Ma C, Liang Y, Zhang C, Lin J |
Nucleic Acids Research | 2023 |
MALAT1 knockdown alleviates the pyroptosis of microglias in diabetic cerebral ischemia via regulating STAT1 mediated NLRP3 transcription.
Zhao N, Hua W, Liu Q, Wang Y, Liu Z, Jin S, Wang B, Pang Y, Qi J, Song Y |
Molecular Medicine | 2023 |
FOXN3 inhibits the progression of ovarian cancer through negatively regulating the expression of RPS15A.
Yang H, Li M, Qi Y |
Human Cell | 2023 |
Overexpression of VIRMA confers vulnerability to breast cancers via the m6A-dependent regulation of unfolded protein response
Lee Q, Song R, Phan DA, Pinello N, Tieng J, Su A, Halstead JM, Wong AC, van Geldermalsen M, Lee BS, Rong B, Cook KM, Larance M, Liu R, Lan F, Tiffen JC, Wong JJ |
Cellular and Molecular Life Sciences | 2023 |
Inhibition of lncRNA PCAT19 promotes breast cancer proliferation
Feng J, Zhang J, Li Y, Cheng W, Liu Y, Chen Z, Duan Y, Yu T, Hu A, Wang T, Zhang H, Li M, Rong Z, Ma F, Guo B |
Cancer Medicine | 2023 |
Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer
Wang X, Hao Y, Chen J, Ding P, Lv X, Zhou D, Li L, Li L, Xu Y, Zhu Y, Zhang W, Chen L, Liao T, He X, Ji QH, Hu W |
Cell Death and Disease | 2023 |
ROCK2-RNA interaction map reveals multiple biological mechanisms underlying tumor progression in renal cell carcinoma.
Hong Z, Chen X, Wang L, Zhou X, He H, Zou G, Liu Q, Wang Y |
Human Cell | 2023 |
Breast cancers as ecosystems: a metabolic perspective
Martino F, Lupi M, Giraudo E, Lanzetti L |
Cellular and Molecular Life Sciences | 2023 |
p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy.
Yang K, Xiao Y, Zhong L, Zhang W, Wang P, Ren Y, Shi L |
Cancer Gene Therapy | 2023 |
Analysis of Bulk Transcriptome Sequencing Data and in vitro Experiments Reveal SIN3A as a Potential Target for Diabetic Foot Ulcer
Chen R, Deng H, Zou L |
2023 | |
Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial Hypertension
Jankowski K, Jagana V, Bisserier M, Hadri L |
Biomedicines | 2023 |
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, Liu B |
Acta pharmaceutica Sinica. B | 2023 |